Abiraterone acetate

For Research Use Only.
Category
Impurities
Cat.No.
NP3330
CAS
154229-18-2
Product Name
Abiraterone acetate
Structure
Structure

Product Details

Description
The acetate form of abiraterone, which blocks the synthesis of androgens by inhibiting CYP17A1. It can be used to treat metastatic, castration-resistant prostate cancer.
Synonyms
CB7630; Zytiga; CB-7630; CB7630; Abiraterone (acetate)
IUPAC Name
[(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
Molecular Weight
391.55
Molecular Formula
C26H33NO2
Canonical SMILES
CC(=O)OC1CCC2(C3CCC4(C(C3CC=C2C1)CC=C4C5=CN=CC=C5)C)C
InChI
InChI=1S/C26H33NO2/c1-17(28)29-20-10-12-25(2)19(15-20)6-7-21-23-9-8-22(18-5-4-14-27-16-18)26(23,3)13-11-24(21)25/h4-6,8,14,16,20-21,23-24H,7,9-13,15H2,1-3H3/t20-,21-,23-,24-,25-,26+/m0/s1
InChIKey
UVIQSJCZCSLXRZ-UBUQANBQSA-N
Melting Point
127-130 °C
Purity
>98%
Appearance
Off-white solid
Application
the treatment of metastatic, castration-resistant prostate cancer
Form
Powder
Packaging
10 g

QC Data

Online Inquiry
×
Top
Inquiry Basket